Cost-savings achieved by eradication of epidemic methicillin-resistant Staphylococcus aureus (EMRSA)-16 from a large teaching hospital

被引:28
作者
Björholt, I
Haglind, E
机构
[1] Univ Gothenburg, Dept Surg, Inst Surg Sci, S-41345 Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Dept Surg, S-41345 Gothenburg, Sweden
关键词
D O I
10.1007/s10096-004-1198-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Methicillin-resistant Staphylococcus aureus continues to be an increasing problem worldwide, although its prevalence in the Nordic countries still is low. In 1997 an unusually readily transmissible strain of epidemic methicillin-resistant S. aureus, EMRSA-16, was introduced by a single patient into a 2,600 bed teaching hospital in Sweden. Despite the standard "search and destroy" policy (Standard MRSA Control Programme), the outbreak took on epidemic proportions. Therefore, the hospital management chose to implement vigorous and costly actions (Intensive MRSA Control Programme). These measures were successful, and the strain was completely eradicated. Whether the actions taken were cost-effective was analysed using an analytical framework in which different scenarios were simulated (decision analytic modelling). Thus, the relative costs and consequences of the Standard MRSA Control Programme and the Intensive MRSA Control Programme could be compared in a simple manner. Coefficients were developed from the observations of the transmission of the bacteria during the period preceding the study period. These were then used to simulate the outcome of the alternative programmes. The uncertainty of the results was explored in sensitivity analyses. The Intensive MRSA Control Programme was shown to be cost saving after slightly more than 24 months of implementation. In conclusion, due to vigorous control efforts, a large EMRSA-16 outbreak in a university hospital was stopped. The initial costs of the control programme were high, but future healthcare resources were saved.
引用
收藏
页码:688 / 695
页数:8
相关论文
共 30 条
[1]   Methicillin-resistant Staphylococcus aureus in two child care centers [J].
Adcock, PM ;
Pastor, P ;
Medley, F ;
Patterson, JE ;
Murphy, TV .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (02) :577-580
[2]  
Adeyemi-Doro AB, 1997, INFECT CONT HOSP EP, V18, P765
[3]   Transmission dynamics of epidemic methicillin-resistant Staphylococcus aureus and vancomycin resistant enterococci in England and Wales [J].
Austin, DJ ;
Anderson, RM .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (04) :883-891
[4]  
Barr JT, 1996, QUALITY LIFE PHARMAC, P1197
[5]   METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AT BOSTON CITY HOSPITAL - BACTERIOLOGIC AND EPIDEMIOLOGIC OBSERVATIONS [J].
BARRETT, FF ;
MCGEHEE, RF ;
FINLAND, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1968, 279 (09) :441-&
[6]  
BOYCE JM, 1995, J CHEMOTHERAPY, V7, P81
[7]   UNCERTAINTY IN THE ECONOMIC-EVALUATION OF HEALTH-CARE TECHNOLOGIES - THE ROLE OF SENSITIVITY ANALYSIS [J].
BRIGGS, A ;
SCULPHER, M ;
BUXTON, M .
HEALTH ECONOMICS, 1994, 3 (02) :95-104
[8]   NEW THREATS TO THE CONTROL OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].
CASEWELL, MW .
JOURNAL OF HOSPITAL INFECTION, 1995, 30 :465-471
[9]   Control of endemic methicillin-resistant Staphylococcus aureus -: A cost-benefit analysis in an intensive care unit [J].
Chaix, C ;
Durand-Zaleski, I ;
Alberti, C ;
Brun-Buisson, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (18) :1745-1751
[10]  
COOPER BS, 2003, HEALTH TECHNOL ASSES, V7, P33